Literature DB >> 28979680

Low concentration of chloroquine enhanced efficacy of cisplatin in the treatment of human ovarian cancer dependent on autophagy.

Jie Zhu1,2, Ya Zheng1,2, Haiyan Zhang1,2, Jing Zhu1,2, Hong Sun1.   

Abstract

BACKGROUND: Cisplatin is a common used anti-tumor drug in ovarian cancer therapy with potent effect. Studies have reported that autophagy works as a cell-survival process in cancer, chloroquine has been added to various chemotherapeutic drugs. In the current study, we aim to evaluate whether chloroquine can enhance the effects of cisplatin in treating ovarian cancer.
METHODS: CCK-8 assay was used to detect cell viability. Transwell assay was used to examine cell migration and invasion. Flow cytometry assay was applied to evaluate cell apoptosis. Western-blot assay was used to detect proteins related to apoptosis, autophagy and the AKT/mTOR pathway.
RESULTS: In the current study, we showed that low concentration of chloroquine alone did not affect cell viability, migration or invasion, but it could enhance the efficacy of cisplatin in inhibiting cell viability, migration and invasion in both SKOV3 and hey cells. Afterwards, we observed that cisplatin triggered apoptosis and autophagy in both SKOV3 and hey cells in a dose-dependent manner. After treatment of cisplatin, SKOV3 and hey cells showed increased apoptotic rate in flow cytometry assay, increased protein levels of cleaved caspase 3, cleaved PARP and Bax, and decreased protein levels of Bcl-2 and Bcl-XL. Cisplatin also induced the formation of autophagosomes and increased autophagy-related proteins ATG 5, ATG 7, Beclin 1 and LC3B II/LC3B I. Meanwhile, cisplatin activated the AKT-mTOR pathway in both SKOV3 and hey cells. Next, chloroquine was added to ovarian cancer cells, flow cytometry assay revealed that chloroquine alone did not affect cell apoptosis and expressions of apoptosis-related proteins, while chloroquine plus cisplatin induced more apoptotic rate than cisplatin alone (p < 0.05). Meanwhile, apoptosis-related proteins had the same change trend. In vivo experiment demonstrated that chloroquine plus cisplatin was more effective than cisplatin alone in suppressing the growth of xenograft tumors, with lower ki-67 expression and higher cleaved caspase 3 expression.
CONCLUSION: Based on our study, we propose that cisplatin activates the AKT/mTOR signaling pathway, which subsequently induces cytoprotective autophagy in ovarian cancer cells. Meanwhile, inhibition of autophagy via chloroquine enhances the anti-tumor effect of cisplatin.

Entities:  

Keywords:  AKT/mTOR signaling pathway; Chloroquine; autophagy; cisplatin; ovarian cancer

Year:  2017        PMID: 28979680      PMCID: PMC5622249     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  36 in total

1.  Moderate progress for ovarian cancer in the last 20 years: prolongation of survival, but no improvement in the cure rate.

Authors:  J Engel; R Eckel; G Schubert-Fritschle; J Kerr; W Kuhn; J Diebold; R Kimmig; J Rehbock; D Hölzel
Journal:  Eur J Cancer       Date:  2002-12       Impact factor: 9.162

2.  Safety and Biologic Response of Pre-operative Autophagy Inhibition in Combination with Gemcitabine in Patients with Pancreatic Adenocarcinoma.

Authors:  Brian A Boone; Nathan Bahary; Amer H Zureikat; A James Moser; Daniel P Normolle; Wen-Chi Wu; Aatur D Singhi; Phillip Bao; David L Bartlett; Lance A Liotta; Virginia Espina; Patricia Loughran; Michael T Lotze; Herbert J Zeh
Journal:  Ann Surg Oncol       Date:  2015-04-24       Impact factor: 5.344

3.  PGRMC1-dependent autophagy by hyperoside induces apoptosis and sensitizes ovarian cancer cells to cisplatin treatment.

Authors:  Xiaofei Zhu; Mingde Ji; Yue Han; Yuanyuan Guo; Wenqiang Zhu; Feng Gao; Xuewen Yang; Chunbing Zhang
Journal:  Int J Oncol       Date:  2017-02-10       Impact factor: 5.650

Review 4.  Autophagy revisited: a conversation with Christian de Duve.

Authors:  Daniel J Klionsky
Journal:  Autophagy       Date:  2008-06-09       Impact factor: 16.016

5.  Inhibition of macroautophagy triggers apoptosis.

Authors:  Patricia Boya; Rosa-Ana González-Polo; Noelia Casares; Jean-Luc Perfettini; Philippe Dessen; Nathanael Larochette; Didier Métivier; Daniel Meley; Sylvie Souquere; Tamotsu Yoshimori; Gérard Pierron; Patrice Codogno; Guido Kroemer
Journal:  Mol Cell Biol       Date:  2005-02       Impact factor: 4.272

6.  Methods in mammalian autophagy research.

Authors:  Noboru Mizushima; Tamotsu Yoshimori; Beth Levine
Journal:  Cell       Date:  2010-02-05       Impact factor: 41.582

7.  Autophagy inhibition for chemosensitization and radiosensitization in cancer: do the preclinical data support this therapeutic strategy?

Authors:  Molly L Bristol; Sean M Emery; Paola Maycotte; Andrew Thorburn; Shweta Chakradeo; David A Gewirtz
Journal:  J Pharmacol Exp Ther       Date:  2013-01-04       Impact factor: 4.030

Review 8.  Chloroquine and its analogs: a new promise of an old drug for effective and safe cancer therapies.

Authors:  V Raja Solomon; Hoyun Lee
Journal:  Eur J Pharmacol       Date:  2009-10-15       Impact factor: 4.432

9.  Galectin-1 overexpression promotes progression and chemoresistance to cisplatin in epithelial ovarian cancer.

Authors:  P Zhang; P Zhang; B Shi; M Zhou; H Jiang; H Zhang; X Pan; H Gao; H Sun; Z Li
Journal:  Cell Death Dis       Date:  2014-01-09       Impact factor: 8.469

10.  Triptolide induces protective autophagy through activation of the CaMKKβ-AMPK signaling pathway in prostate cancer cells.

Authors:  Fei Zhao; Weiwei Huang; Zhe Zhang; Lin Mao; Yangyang Han; Jun Yan; Ming Lei
Journal:  Oncotarget       Date:  2016-02-02
View more
  9 in total

1.  Downregulation of BAG3 attenuates cisplatin resistance by inhibiting autophagy in human epithelial ovarian cancer cells.

Authors:  Shuang Qiu; Liang Sun; Yan Zhang; Shiyu Han
Journal:  Oncol Lett       Date:  2019-06-19       Impact factor: 2.967

2.  miRNA-574-3p inhibits metastasis and chemoresistance of epithelial ovarian cancer (EOC) by negatively regulating epidermal growth factor receptor (EGFR).

Authors:  Pengnan Zhang; Jie Zhu; Ya Zheng; Haiyan Zhang; Hong Sun; Shujun Gao
Journal:  Am J Transl Res       Date:  2019-07-15       Impact factor: 4.060

3.  LncRNA GAS8-AS1 Inhibits Ovarian Cancer Progression Through Activating Beclin1-Mediated Autophagy.

Authors:  Ying-Ji Fang; Ping Jiang; Hui Zhai; Jing-Sen Dong
Journal:  Onco Targets Ther       Date:  2020-10-14       Impact factor: 4.147

Review 4.  Dissecting pharmacological effects of chloroquine in cancer treatment: interference with inflammatory signaling pathways.

Authors:  Lokman Varisli; Osman Cen; Spiros Vlahopoulos
Journal:  Immunology       Date:  2019-12-22       Impact factor: 7.397

Review 5.  Chloroquine against malaria, cancers and viral diseases.

Authors:  Wenmin Zhou; Hui Wang; Yuqi Yang; Zhe-Sheng Chen; Chang Zou; Jianye Zhang
Journal:  Drug Discov Today       Date:  2020-09-16       Impact factor: 7.851

6.  Chloroquine reverses chemoresistance via upregulation of p21WAF1/CIP1 and autophagy inhibition in ovarian cancer.

Authors:  Jae Ryoung Hwang; Woo Young Kim; Young-Jae Cho; Ji-Yoon Ryu; Jung-Joo Choi; Soo Young Jeong; Myeong-Sun Kim; Ji Hye Kim; E Sun Paik; Yoo-Young Lee; Hee-Dong Han; Jeong-Won Lee
Journal:  Cell Death Dis       Date:  2020-12-04       Impact factor: 8.469

7.  Combination Chemotherapy with Cisplatin and Chloroquine: Effect of Encapsulation in Micelles Formed by Self-Assembling Hybrid Dendritic-Linear-Dendritic Block Copolymers.

Authors:  Rebeca González-Pastor; Alexandre Lancelot; Violeta Morcuende-Ventura; María San Anselmo; Teresa Sierra; José L Serrano; Pilar Martin-Duque
Journal:  Int J Mol Sci       Date:  2021-05-14       Impact factor: 5.923

8.  Autophagy Inhibition Promotes Bevacizumab-induced Apoptosis and Proliferation Inhibition in Colorectal Cancer Cells.

Authors:  Zhi Zhao; Guanggai Xia; Ni Li; Ruping Su; Xiao Chen; Li Zhong
Journal:  J Cancer       Date:  2018-09-08       Impact factor: 4.207

9.  Integrative network analysis identifies potential targets and drugs for ovarian cancer.

Authors:  Tianyu Zhang; Liwei Zhang; Fuhai Li
Journal:  BMC Med Genomics       Date:  2020-09-21       Impact factor: 3.063

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.